Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Q423846
2. 2-[6-[4,5-bis(2-hydroxypropoxy)-2-(2-hydroxypropoxymethyl)-6-methoxyoxan-3-yl]oxy-4,5-dimethoxy-2-(methoxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)-5-methoxyoxane-3,4-diol
| Molecular Weight | 748.8 g/mol |
|---|---|
| Molecular Formula | C32H60O19 |
| XLogP3 | -3.9 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 19 |
| Rotatable Bond Count | 21 |
| Exact Mass | 748.37287968 g/mol |
| Monoisotopic Mass | 748.37287968 g/mol |
| Topological Polar Surface Area | 241 Ų |
| Heavy Atom Count | 51 |
| Formal Charge | 0 |
| Complexity | 952 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 18 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Market Place
ABOUT THIS PAGE
A Hypromellosum manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hypromellosum, including repackagers and relabelers. The FDA regulates Hypromellosum manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hypromellosum API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Hypromellosum supplier is an individual or a company that provides Hypromellosum active pharmaceutical ingredient (API) or Hypromellosum finished formulations upon request. The Hypromellosum suppliers may include Hypromellosum API manufacturers, exporters, distributors and traders.
click here to find a list of Hypromellosum suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Hypromellosum DMF (Drug Master File) is a document detailing the whole manufacturing process of Hypromellosum active pharmaceutical ingredient (API) in detail. Different forms of Hypromellosum DMFs exist exist since differing nations have different regulations, such as Hypromellosum USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Hypromellosum DMF submitted to regulatory agencies in the US is known as a USDMF. Hypromellosum USDMF includes data on Hypromellosum's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Hypromellosum USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Hypromellosum suppliers with USDMF on PharmaCompass.
Hypromellosum Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Hypromellosum GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Hypromellosum GMP manufacturer or Hypromellosum GMP API supplier for your needs.
A Hypromellosum CoA (Certificate of Analysis) is a formal document that attests to Hypromellosum's compliance with Hypromellosum specifications and serves as a tool for batch-level quality control.
Hypromellosum CoA mostly includes findings from lab analyses of a specific batch. For each Hypromellosum CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Hypromellosum may be tested according to a variety of international standards, such as European Pharmacopoeia (Hypromellosum EP), Hypromellosum JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hypromellosum USP).
LOOKING FOR A SUPPLIER?
